Gene Signal Company

Gene Signal is a research and development based biotechnology company focused on discovering genes involved in the regulation of angiogenesis. Gene Signal's ophthalmic research program is pioneering targeted upstream blockade of pathological angiogenesis through the inhibition of Insulin Receptor Substrate 1 (IRS-1)
Industry: Gene Therapy
Headquarters: Vaud

Visit Website
Register and Claim Ownership